Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
Semax
ACTH-fragment analogue neuropeptide research material
- Neuroprotection models
- Cognition
- Ischaemia research
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is Semax?
Semax is an ACTH-fragment-derived neuropeptide investigated in neurotrophic signalling, ischaemia models, cognition and stress-response biology. Much of the literature comes from Russian and regional research programmes, with a mixture of preclinical and limited human studies. Bear Biotech presents Semax as a laboratory research material rather than a cognitive-performance product.
Limited human studies and preclinical research, largely regional
Research focus
Key research areas
Semax research: neurotrophic and stress-response pathways
Semax is an ACTH(4-7)-related peptide extended with Pro-Gly-Pro and studied in neuronal and ischaemia models. The evidence is regionally concentrated and not widely replicated. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Neuroprotection models
- Cognition
- Ischaemia research
Representative primary research
Representative research
A rat study measured Semax binding and basal-forebrain BDNF protein.
- Semax binds specifically and increases brain-derived neurotrophic factor protein in rat basal forebrain ↗ Original animal research.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- Semax
- Research category
- ACTH-fragment analogue neuropeptide research material
- Evidence position
- Limited human studies and preclinical research, largely regional
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Which neuroprotection models are used to study Semax?
Semax is studied in neuroprotection and cognition models, including experimental contexts related to ischaemia. Researchers focus on measured neural and behavioural endpoints.
Why should ischaemia and cognition findings be evaluated separately?
Ischaemia research and cognition studies use different designs and cannot be treated as interchangeable evidence. The precise Semax material and model must be documented.
How does the regional concentration of Semax studies limit interpretation?
Semax has limited human studies and preclinical research, much of it regionally concentrated. Broader clinical conclusions are not established.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.